Announcement under Regulation 30 (LODR) - Appointment of Statutory Auditor M/s Sarang Shivajirao Chavan & Associates
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd's Board of Directors met on August 25, 2025 and approved two key items. First, M/s Sarang Shivajirao Chavan & Associates has been appointed as the new Statutory Auditor of the company. Second, Mr. Vivek Mukesh Yadav (DIN: 10778075) has been appointed as an Independent Director of the company with effect from August 25, 2025. Mr. Yadav brings experience in finance, accounts, and corporate management. The board confirmed that Mr. Yadav is not debarred from holding director position by SEBI or any other authority. The outcome was signed by Ms. Chaitali Kalpataru Shah, Director & CFO.
These are routine governance-level appointments with no immediate material impact on stock price or operations. Shareholders should note a change in the company's statutory auditor, which is worth monitoring for any future audit-related disclosures.